Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic

Biologicals. 2021 Jan:69:76-82. doi: 10.1016/j.biologicals.2020.11.003. Epub 2020 Nov 19.

Abstract

This International Alliance for Biological Standardization COVID-19 webinar was organized to provide an update on the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2, none months after COVID-19 was declared a public health emergency of international concern. It brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries.

Keywords: Epidemiology; Immunology; SARS-CoV-2; Vaccine; Virology.

Publication types

  • Congress

MeSH terms

  • Antibodies, Neutralizing / biosynthesis
  • Antibodies, Viral / biosynthesis
  • Biological Products / isolation & purification
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / adverse effects
  • COVID-19 Vaccines* / isolation & purification
  • COVID-19* / epidemiology
  • COVID-19* / etiology
  • COVID-19* / therapy
  • Clinical Trials as Topic
  • Drug Development / trends
  • Europe / epidemiology
  • Humans
  • Immunity, Cellular
  • Pandemics*
  • SARS-CoV-2* / genetics
  • SARS-CoV-2* / immunology
  • SARS-CoV-2* / pathogenicity
  • Safety
  • World Health Organization

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Biological Products
  • COVID-19 Vaccines